Inventor · disambiguated record
Paul R. Hartig
Also filed as: HARTIG PAUL R · HARTIG PAUL RICHARD
33 granted patents·6 pending applications·747 citations·filing 1989–2002
98Inventor score
Files withSYNAPTIC PHARMA CORP34NEUROGENETIC CORP2DU PONT MERCK PHARMA1LUNDBECK & CO AS H1SYNAPATIC PHARMACEUTICAL CORP1
Top patents by PatentIndex Score
39 records- 0195US5360735ADNA encoding a human 5-HT1F receptor, vectors, and host cellsSYNAPTIC PHARMA CORP·Filed 1992·Granted Nov 1, 1994·98 cites·13 claims
- 0293US5661024ADNA encoding a human serotonic (5-HT2) receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 1994·Granted Aug 26, 1997·91 cites·18 claims
- 0390US5403847AUse of α1C specific compounds to treat benign prostatic hyperlasiaSYNAPTIC PHARMA CORP·Filed 1992·Granted Apr 4, 1995·70 cites·52 claims
- 0487US5155218ADna encoding human 5-ht1d receptorsNEUROGENETIC CORP·Filed 1990·Granted Oct 13, 1992·53 cites·14 claims
- 0585US6383762B1Methods of obtaining compounds that interact with a human serotonin (5-HT2) receptorSYNAPTIC PHARMA CORP·Filed 1998·Granted May 7, 2002·36 cites·5 claims
- 0684US5885785ADNA encoding a human serotonin (5-HT2) receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 1996·Granted Mar 23, 1999·35 cites·11 claims
- 0782US6331401B1Uses of the 5-HT4 receptorSYNAPTIC PHARMA CORP·Filed 1998·Granted Dec 18, 2001·30 cites·11 claims
- 0880US5658786ADNA encoding rat taurine transporter and uses thereofSYNAPTIC PHARMA CORP·Filed 1993·Granted Aug 19, 1997·38 cites·13 claims
- 0980US5053337ADNA encoding an α2B -adrenergic receptorNEUROGENETIC CORP·Filed 1989·Granted Oct 1, 1991·33 cites·37 claims
- 1074US6225115B1DNA encoding taurine and GABA transporters and uses thereofSYNAPTIC PHARMA CORP·Filed 1999·Granted May 1, 2001·33 cites·17 claims
- 1174US5935925AMethods of treating migraine and compounds useful for such methodsSYNAPTIC PHARMA CORP·Filed 1995·Granted Aug 10, 1999·23 cites·8 claims
- 1273US5595880ADNA encoding an α2B adrenergic receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 1992·Granted Jan 21, 1997·27 cites·5 claims
- 1371US5578611AUse of α-1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1994·Granted Nov 26, 1996·21 cites·36 claims
- 1470US5472866ADNA encoding 5-HT4A serotonin receptorsSYNAPTIC PHARMA CORP·Filed 1992·Granted Dec 5, 1995·20 cites·26 claims
- 1569US5766879ADNA encoding 5-HT4 serotonin receptors and uses thereofSYNAPTIC PHARMA CORP·Filed 1993·Granted Jun 16, 1998·18 cites·16 claims
- 1661US5786157ADNA encoding human 5-HT1D receptors and uses thereofSYNAPATIC PHARMACEUTICAL CORP·Filed 1994·Granted Jul 28, 1998·13 cites·6 claims
- 1760US5780485AUse of α1c specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1995·Granted Jul 14, 1998·13 cites·56 claims
- 1860US5476782ADNA encoding a human 5-HT1E receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 1995·Granted Dec 19, 1995·15 cites·13 claims
- 1959US6015819AUse of alpha-1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1993·Granted Jan 18, 2000·10 cites·58 claims
- 2057US6468767B1DNA encoding a human dopamine D1 receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Oct 22, 2002·13 cites·3 claims
- 2157US2002098548A1DNA encoding a human serotonin (5-HT2) receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Application pending·0 cites
- 2256US2003008823A1DNA encoding a human 5-HT1F receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 2002·Application pending·0 cites
- 2354US5990128Aα1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1995·Granted Nov 23, 1999·9 cites·20 claims
- 2452US5652113ADNA encoding a human 5-HT 1F receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 1994·Granted Jul 29, 1997·6 cites·11 claims
- 2551US6939680B2DNA encoding a human dopamine D1 receptor and uses thereofLUNDBECK & CO AS H·Filed 2002·Granted Sep 6, 2005·0 cites·6 claims
- 2651US2003022900A1Compositions comprising alpha-1C specific compoundsSYNAPTIC PHARMA CORP·Filed 2002·Application pending·0 cites
- 2749US2002115149A1DNA encoding human 5-HT1D receptors and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Application pending·0 cites
- 2847US5750528ABlockade of neuronal m-channels as a therapeutic approach to the treatment of neurological diseaseDU PONT MERCK PHARMA·Filed 1995·Granted May 12, 1998·13 cites·7 claims
- 2947US5639652ADNA encoding a human 5-HT1F receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 1993·Granted Jun 17, 1997·4 cites·15 claims
- 3047US2002081661A1DNA encoding 5-HT4 serotonin receptors and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Application pending·0 cites
- 3146US2003143729A1DNA encoding taurine and GABA transporters and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Application pending·0 cites
- 3244US5786155AMethods for identifying a compound that binds to a human 5-HT 1E receptorSYNAPTIC PHARMA CORP·Filed 1995·Granted Jul 28, 1998·5 cites·10 claims
- 3343US5882855ADNA encoding a human dopamine D1 receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 1991·Granted Mar 16, 1999·6 cites·19 claims
- 3440US6127131ADNA encoding a glycine transporter and uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Oct 3, 2000·2 cites·8 claims
- 3540US6096507AMethods for identifying a compound that binds to a human 5-HT1E receptorSYNAPTIC PHARMA CORP·Filed 1998·Granted Aug 1, 2000·3 cites·6 claims
- 3637US6475746B1Method of obtaining a composition comprising a 5-HT1D selective compoundSYNAPTIC PHARMA CORP·Filed 1999·Granted Nov 5, 2002·1 cites·7 claims
- 3736US6602888B2Use of α1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1999·Granted Aug 5, 2003·1 cites·31 claims
- 3836US6406859B1DNA encoding a 5-HT 1F receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 1999·Granted Jun 18, 2002·2 cites·3 claims
- 3934US5756348ADNA encoding a glycine transporter and uses thereofSYNAPTIC PHARMA CORP·Filed 1992·Granted May 26, 1998·5 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →